Related Experiment Videos
[Cardiac hypertrophy and calcium signaling]
Clinical Calcium
|March 19, 2005
Summary
Intracellular calcium (Ca2+) signals cardiac hypertrophy. Calcineurin inhibitors like cyclosporin A and FK506 block this process, potentially preventing heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Signaling
Context:
- Intracellular calcium (Ca2+) is a known signaling molecule in cardiac hypertrophy.
- Recent research highlights the critical role of the calcium-dependent phosphatase, calcineurin, in this process.
Purpose:
- To investigate the role of calcineurin in cardiac hypertrophy.
- To evaluate the potential of calcineurin inhibitors for preventing cardiac hypertrophy and heart failure.
Summary:
- Calcineurin, a calcium-dependent phosphatase, is implicated in cardiac hypertrophy.
- Administration of calcineurin inhibitors, cyclosporin A and FK506, has been shown to inhibit the development of cardiac hypertrophy.
Impact:
- Inhibiting calcineurin activity presents a potential therapeutic strategy for preventing cardiac hypertrophy.
- This approach may offer benefits in managing and preventing heart failure.